NELAX
Price
$59.74
Change
+$0.31 (+0.52%)
Updated
Jan 30 closing price
Net Assets
148.59M
REMIX
Price
$14.54
Change
+$0.02 (+0.14%)
Updated
Jan 30 closing price
Net Assets
1.09B
Ad is loading...

NELAX vs REMIX

Header iconNELAX vs REMIX Comparison
Open Charts NELAX vs REMIXBanner chart's image
Nuveen Equity Long/Short A
Price$59.74
Change+$0.31 (+0.52%)
VolumeN/A
Net Assets148.59M
Standpoint Multi-Asset Investor
Price$14.54
Change+$0.02 (+0.14%)
VolumeN/A
Net Assets1.09B
NELAX vs REMIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NELAX vs. REMIX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NELAX is a StrongBuy and REMIX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
REMIX has more cash in the bank: 1.09B vs. NELAX (149M). NELAX pays higher dividends than REMIX: NELAX (3.65) vs REMIX (0.52). NELAX was incepted earlier than REMIX: NELAX (16 years) vs REMIX (5 years). NELAX is a more actively managed with annual turnover of: 77.00 vs. REMIX (8.00). NELAX (2500) and REMIX (2500) have matching initial minimum investment requirements. NELAX annual gain was more profitable for investors over the last year : 17.15 vs. REMIX (12.28). REMIX return over 5 years is better than : 65.43 vs. NELAX (56.26).
NELAXREMIXNELAX / REMIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years5 years-
Gain YTD2.6641.823146%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets149M1.09B14%
Annual Yield % from dividends3.650.52698%
Returns for 1 year17.1512.28140%
Returns for 3 years20.2922.8989%
Returns for 5 years56.2665.4386%
Returns for 10 years91.67N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RRGB6.380.18
+2.90%
Red Robin Gourmet Burgers
ATR158.131.02
+0.65%
AptarGroup
XERS3.660.01
+0.27%
Xeris Biopharma Holdings
CNTA16.91-0.05
-0.29%
Centessa Pharmaceuticals plc
SCNI3.52-0.01
-0.41%
Scinai Immunotherapeutics Ltd.